Lower Cancer Survival Seen for Residence in Redlined Neighborhoods

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 27, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 27, 2025 -- For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at five and 10 years, according to a study published online Jan. 27 in Cancer.

Kristine A. Karvonen, M.D., from the University of Washington School of Medicine in Seattle, and colleagues determined case redlining status among individuals younger than 40 years of age living in Seattle and Tacoma between 2000 and 2019 with incident cancer. Five- and 10-year survival and hazard ratio of death were determined according to redlined status.

The researchers found that among 4,355 cases, overall survival at five years was lower among those residing in redlined versus unexposed neighborhoods (85.1 versus 90.3 percent). At 10 years, these survival differences persisted. Redlined-exposed individuals with cancer had a higher unadjusted hazard of death than redlined-unexposed (hazard ratio,1.62). Mortality remained higher for redlined cases in the fully adjusted model (hazard ratio, 1.32). No effect modification was seen from area-level poverty in the relationship between redlining and death.

"This study agrees with previous research that living in an area that was previously redlined nearly a century ago is associated with poor outcomes for patients with cancer today and adds young patients with cancer as a population at risk," Karvonen said in a statement. "Therefore, our study names racism as a potential driver of outcomes for young patients with cancer."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-28 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords